As part of an ongoing probe into the influence of the medical device and pharmaceutical industries on healthcare decisions, US senator Charles Grassley (Republican – Iowa) has sent out new demands – this time to disease and medical advocacy groups – calling for information about any industry money these groups have received1
...
Please login to read the full article.
